• Fernanda Borges is proponent, Vice-Chair and Grant Holder scientific representative of the COST ACTION CA15135.
    Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)

  • Alexandra Gaspar is MC substitute of the COST ACTION CA15135
    Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)

  • Fernanda Borges is the MC substitute of the COST ACTION CM1406
    Epigenetic Chemical Biology

  • Fernanda Borges is the responsible for creating an international doctoral program between the University of Cagliari (doctoral program in Scienze della vita, dell’ambiente and del pharmaco) and the University of Porto (doctoral program in Chemistry

  • Fernanda Borges is the coordinator of the University of Porto, appointed by FCUP, in the Paul Ehrlich MedChem network (Euro PhD Network)